New study aims to uncover hidden hormone imbalance in common adrenal tumors

NCT ID NCT06344143

Recruiting now Knowledge-focused Sponsor: The Cleveland Clinic Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 19 times

Summary

This study aims to find the best combination of tests to detect mild autonomous cortisol secretion (MACS) in people with adrenal incidentalomas—non-cancerous tumors found by chance on scans. Researchers will enroll 20 adults and compare several diagnostic tests, including blood, saliva, and urine measurements, to see which are most accurate. Participants will be followed for 4 years to track any changes in their condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MILD AUTONOMOUS CORTISOL SECRETION (MACS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

The Cleveland Clinic Foundation
RECRUITING

Cleveland, Ohio, 44195, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MILD AUTONOMOUS CORTISOL SECRETION (MACS)